<DOC>
	<DOCNO>NCT00452426</DOCNO>
	<brief_summary>Patients routinely receive sedation colonoscopy upper endoscopy ( esophagogastroduodenoscopy ; EGD ) procedure . Propofol sedative use procedure . The purpose study determine CAPS device enables physician/registered nurse ( RN ) team safely effectively administer propofol sedation colonoscopy EGD procedures relative current sedation practice .</brief_summary>
	<brief_title>Safety Effectiveness Computer-Assisted Personalized Sedation ( CAPS ) Device Propofol Delivery During Endoscopy</brief_title>
	<detailed_description />
	<mesh_term>Propofol</mesh_term>
	<criteria>≥ 18 year old Able comprehend , sign , date write informed consent form English primary language Undergoing nonemergent EGD colonoscopy Have take nothing mouth minimum 6 hour prior study procedure American Society Anesthesiologists ( ASA ) Class I , II III Allergy inability tolerate study medication component study medication Investigator anticipate great 45 minute procedure time due know anatomical difficulty Currently use fentanyl patch History diagnose sleep apnea History diagnose gastroparesis Baseline oxygen saturation &lt; 90 % ( room air ) Pregnant nursing female Body mass index ( BMI ) ≥ 35 Participation clinical trial within past 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Propofol</keyword>
	<keyword>Diprivan</keyword>
	<keyword>Colonoscopy</keyword>
	<keyword>Endoscopy , Digestive System</keyword>
	<keyword>Conscious Sedation</keyword>
</DOC>